11 August 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on five medicines.

Brentuximab vedotin (Adcetris) was accepted for use together with chemotherapy for the first-line treatment of adults with advanced Hodgkin lymphoma.

Read SMC press release